Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
MATIASGUIU, X; FORTEZA, J; PRAT, J
MIXED STRUMaL aND MUCINOUS CaRCINOID-TUMOR OF THE OVaRY
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 14 179-183. .
-
PUIG, L; ALEGRE, M; COSTA, I; MATIASGUIU, X; DEMORAGAS, JM
OVEREXPRESSION OF P53 IN DISSEMINaTED SUPERFICIaL aCTINIC POROKERaTOSIS WITH aND WITHOUT MaLIGNaNT DEGENERaTION
ARCH DERMATOL 131 353-354. .
-
MATIASGUIU, X; PEIRO, G; ESQUIUS, J; OLIVA, E; CABEZAS, R; COLOMER, A; PRAT, J
PROLIFERaTIVE aCTIVITY IN C-CELL HYPERPLaSIa aND MEDULLaRY-THYROID CaRCINOMa - EVaLUaTION BY PCNa IMMUNOHISTOCHEMISTRY aND aGNORS STaINING
PATHOL RES PRACT 191 42-47. .
-
PONS, C; COSTA, I; VONSCHILLING, B; MATIASGUIU, X; PRAT, J
ANTIGEN RETRIEVaL BY WET aUTOCLaVING FOR P53 IMMUNOSTaINING
APPL IMMUNOHISTO M M 3 265-267. .
-
MATIASGUIU, X; CAIXAS, A; COSTA, I; CABEZAS, R; PRAT, J
COMPOUND MEDULLaRY PaPILLaRY CaRCINOMa OF THE THYROID - TRUE MIXED VERSUS COLLISION TUMOR (VOL 25, PG 183, 1994)
Histopathology 26 104-104. .
-
MATIASGUIU, X; COLOMER, A; KOMMINOTH, P; PRAT, J; WOLFE, H
RET PROTOONCOGENE MESSENGER-RNa EXPRESSION IN PHEOCHROMOCYTOMa
LABORATORY INVESTIGATION 72 55-55. .
-
COSTA, I; MATIASGUIU, X; MUSULEN, E; CUATRECASAS, M; PRAT, J
P53 EXPRESSION IN OVaRIaN EPITHELIaL STROMaL TUMORS
LABORATORY INVESTIGATION 72 88-88. .
-
CUATRECASAS, M; MATIASGUIU, X; PRAT, J
K-RaS MUTaTION PaTTERN SUPPORTS a CLONaL NaTURE OF SYNCHRONOUS OVaRIaN aND aPPENDICEaL MUCINOUS TUMORS
LABORATORY INVESTIGATION 72 88-88. .
-
MATIASGUIU, X; PRAT, J
PERITONEaL STRUMOSIS - CRITICaL COMMENTaRY
PATHOL RES PRACT 190 1086-1086. .
-
MATIASGUIU, X; PONS, C; MUNOZ, J; PRAT, J
BIOTIN-CONTaINING INTRaNUCLEaR INCLUSIONS IN TUMOR-CELLS - POSSIBLE CaUSE FOR MISINTERPRETING NUCLEaR aNTIGEN IMMUNOSTaINING
AMERICAN JOURNAL OF CLINICAL PATHOLOGY 102 706-707. .
-
KOMMINOTH, P; KUNZ, E; HIORT, O; SCHRODER, S; MATIASGUIU, X; CHRISTIANSEN, G; ROTH, J; HEITZ, PU
DETECTION OF RET PROTOONCOGENE POINT MUTaTIONS IN PaRaFFIN-EMBEDDED PHEOCHROMOCYTOMa SPECIMENS BY NONRaDIOaCTIVE SINGLE-STRaND CONFORMaTION POLYMORPHISM aNaLYSIS aND DIRECT SEQUENCING
AMERICAN JOURNAL OF PATHOLOGY 145 922-929. .
-
PRAT, J; OLIVA, E; LERMA, E; VAQUERO, M; MATIASGUIU, X
UTERINE PaPILLaRY SEROUS aDENOCaRCINOMa - a 10-CaSE STUDY OF P53 aND C-ERBB-2 EXPRESSION aND DNa CONTENT
CANCER 74 1778-1783. .
[doi:10.1002/1097-0142(19940915)74:6<1778::AID-CNCR2820740621>3.0.CO;2-5]
Projects
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
